{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:04:10Z","timestamp":1793037850610,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00213-024-06606-9","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T05:01:45Z","timestamp":1716872505000},"page":"1905-1914","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Co-administration of probiotics and vitamin D reduced disease severity and complications in patients with Parkinson\u2019s disease: a randomized controlled clinical trial"],"prefix":"10.1007","volume":"241","author":[{"given":"Alireza","family":"Zali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Hajyani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehri","family":"Salari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2780-3447","authenticated-orcid":false,"given":"Maryam","family":"Tajabadi-Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir M.","family":"Mortazavian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahareh","family":"Pakpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"key":"6606_CR1","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.parkreldis.2012.10.008","volume":"19","author":"A Abdolahi","year":"2013","unstructured":"Abdolahi A, Scoglio N, Killoran A, Dorsey ER, Biglan KM (2013) Potential reliability and validity of a modified version of the Unified Parkinson\u2019s Disease Rating Scale that could be administered remotely. Parkinsonism Relat Disord 19:218\u2013221","journal-title":"Parkinsonism Relat Disord"},{"key":"6606_CR2","doi-asserted-by":"publisher","first-page":"115788","DOI":"10.1016\/j.biopha.2023.115788","volume":"168","author":"Y A\u00e7ar","year":"2023","unstructured":"A\u00e7ar Y, A\u011fag\u00fcnd\u00fcz D, De Cicco P, Capasso R (2023) Flavonoids: their putative neurologic roles, epigenetic changes, and gut microbiota alterations in Parkinson\u2019s disease. Biomed Pharmacother 168:115788","journal-title":"Biomed Pharmacother"},{"key":"6606_CR3","doi-asserted-by":"publisher","first-page":"101441","DOI":"10.1016\/j.inat.2021.101441","volume":"27","author":"AY Azzam","year":"2022","unstructured":"Azzam AY, Ghozy S, Azab MA (2022) Vitamin D and its\u2019 role in Parkinson\u2019s disease patients with SARS-CoV-2 infection. A review article. Interdiscip Neurosurg 27:101441","journal-title":"Interdiscip Neurosurg"},{"key":"6606_CR4","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1080\/01635581.2020.1784442","volume":"73","author":"M Barati","year":"2021","unstructured":"Barati M, Jabbari M, Nickho H, Esparvarinha M, Javadi Mamaghani A, Majdi H, Fathollahi A, Davoodi SH (2021) Regulatory T cells in bioactive peptides-Induced oral tolerance; a two-edged Sword related to the risk of chronic diseases: a systematic review. Nutr Cancer 73:956\u2013967","journal-title":"Nutr Cancer"},{"key":"6606_CR5","doi-asserted-by":"crossref","unstructured":"Barichella M, Garri F, Caronni S, Bolliri C, Zocchi L, Macchione MC, Ferri V, Calandrella D, Pezzoli G (2022) Vitamin D Status and Parkinson\u2019s Disease. Brain Sci, 12","DOI":"10.3390\/brainsci12060790"},{"key":"6606_CR6","doi-asserted-by":"crossref","unstructured":"Batebi S, Masjedi Arani A, Jafari M, Sadeghi A, Saberi Isfeedvajani M, Davazdah Emami MH (2019) Validity and reliability of the Persian Version of Leeds Dyspepsia Questionnaire. Galen Med J, 8, e1609","DOI":"10.31661\/gmj.v8i0.1609"},{"key":"6606_CR7","doi-asserted-by":"crossref","unstructured":"Bivona G, Agnello L, Bellia C, Iacolino G, Scazzone C, Lo Sasso B, Ciaccio M (2019) Non-skeletal activities of vitamin D: from physiology to Brain Pathology. Med (Kaunas), 55","DOI":"10.3390\/medicina55070341"},{"key":"6606_CR8","first-page":"289","volume":"21","author":"S Borzabadi","year":"2018","unstructured":"Borzabadi S, Oryan S, Eidi A, Asemi Z (2018) The effects of probiotic supplementation on gene expression related to inflammation, insulin and lipid in patients with Parkinson\u2019s disease: a randomized, double-blind, placebocontrolled trial. Arch Iran Med 21:289\u2013295","journal-title":"Arch Iran Med"},{"key":"6606_CR9","doi-asserted-by":"crossref","unstructured":"Breydo L, Wu JW, Uversky VN (2012) \u03b1-Synuclein misfolding and Parkinson\u2019s disease. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 1822:261\u2013285","DOI":"10.1016\/j.bbadis.2011.10.002"},{"key":"6606_CR10","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.3390\/nu15173839","volume":"15","author":"ZK Bytowska","year":"2023","unstructured":"Bytowska ZK, Korewo-Labelle D, Kowalski K, Libionka W, Przew\u0142\u00f3cka K, Kloc W, Kaczor JJ (2023) Impact of 12 weeks of vitamin D3 administration in Parkinson\u2019s patients with deep brain stimulation on kynurenine pathway and inflammatory status. Nutrients 15:3839","journal-title":"Nutrients"},{"key":"6606_CR11","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.18632\/aging.102927","volume":"12","author":"V Castelli","year":"2020","unstructured":"Castelli V, d\u2019Angelo M, Lombardi F, Alfonsetti M, Antonosante A, Catanesi M, Benedetti E, Palumbo P, Cifone MG, Giordano A (2020) Effects of the probiotic formulation SLAB51 in in vitro and in vivo Parkinson\u2019s disease models. Aging 12:4641","journal-title":"Aging"},{"key":"6606_CR12","doi-asserted-by":"crossref","unstructured":"Chang KH, Chen CM (2020) The Role of Oxidative Stress in Parkinson\u2019s Disease. Antioxid (Basel), 9","DOI":"10.3390\/antiox9070597"},{"key":"6606_CR13","doi-asserted-by":"crossref","unstructured":"Chen M, Mor DE (2023) Gut-to-Brain alpha-Synuclein Transmission in Parkinson\u2019s Disease: Evidence for Prion-like Mechanisms. Int J Mol Sci, 24","DOI":"10.3390\/ijms24087205"},{"key":"6606_CR14","doi-asserted-by":"crossref","unstructured":"Choi AR, Patra JK, Kim WJ, Kang SS (2018) Antagonistic Activities and Probiotic Potential of Lactic Acid Bacteria Derived From a Plant-Based Fermented Food. Front Microbiol, 9, 1963","DOI":"10.3389\/fmicb.2018.01963"},{"key":"6606_CR15","doi-asserted-by":"publisher","first-page":"100060","DOI":"10.1016\/j.bbih.2020.100060","volume":"4","author":"I Deng","year":"2020","unstructured":"Deng I, Corrigan F, Zhai G, Zhou XF, Bobrovskaya L (2020) Lipopolysaccharide animal models of Parkinson\u2019s disease: recent progress and relevance to clinical disease. Brain Behav Immun Health 4:100060","journal-title":"Brain Behav Immun Health"},{"key":"6606_CR16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/JPD-130230","volume":"3","author":"V Dias","year":"2013","unstructured":"Dias V, Junn E, Mouradian MM (2013) The role of oxidative stress in Parkinson\u2019s disease. J Parkinsons Dis 3:461\u2013491","journal-title":"J Parkinsons Dis"},{"key":"6606_CR17","first-page":"935429","volume":"2013","author":"SM Fereshtehnejad","year":"2013","unstructured":"Fereshtehnejad SM, Hadizadeh H, Farhadi F, Shahidi GA, Delbari A, Lokk J (2013) Reliability and validity of the persian version of the fatigue severity scale in idiopathic Parkinson\u2019s disease patients. Parkinsons Dis 2013:935429","journal-title":"Parkinsons Dis"},{"key":"6606_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.celrep.2019.12.078","volume":"30","author":"ME Goya","year":"2020","unstructured":"Goya ME, Xue F, Sampedro-Torres-Quevedo C, Arnaouteli S, Riquelme-Dominguez L, Romanowski A, Brydon J, Ball KL, Stanley-Wall NR, Doitsidou M (2020) Probiotic Bacillus subtilis protects against \u03b1-synuclein aggregation in C. Elegans. Cell Rep 30:367\u2013380 e7","journal-title":"Cell Rep"},{"key":"6606_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/labmed\/lmx087","volume":"49","author":"M Jabbari","year":"2018","unstructured":"Jabbari M, Kheirouri S, Alizadeh M (2018) Decreased serum levels of ghrelin and brain-derived neurotrophic factor in Premenopausal Women with metabolic syndrome. Lab Med 49:140\u2013146","journal-title":"Lab Med"},{"key":"6606_CR20","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386:896\u2013912","journal-title":"Lancet"},{"key":"6606_CR21","first-page":"136","volume":"66","author":"H Kaviani","year":"2008","unstructured":"Kaviani H, Mousavi AS (2008) Psychometric properties of the Persian version of Beck anxiety inventory (BAI). Tehran Univ Med J 66:136\u2013140","journal-title":"Tehran Univ Med J"},{"key":"6606_CR22","doi-asserted-by":"crossref","unstructured":"Kechagia M, Basoulis D, Konstantopoulou S, Dimitriadi D, Gyftopoulou K, Skarmoutsou N, Fakiri EM (2013) Health benefits of probiotics: a review. ISRN Nutr, 2013, 481651","DOI":"10.5402\/2013\/481651"},{"key":"6606_CR23","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1093\/brain\/awq059","volume":"133","author":"PA Kempster","year":"2010","unstructured":"Kempster PA, O\u2019Sullivan SS, Holton JL, Revesz T, Lees AJ (2010) Relationships between age and late progression of Parkinson\u2019s disease: a clinico-pathological study. Brain 133:1755\u20131762","journal-title":"Brain"},{"key":"6606_CR24","doi-asserted-by":"crossref","unstructured":"Khanal R, Nemere I (2007) Membrane receptors for vitamin D metabolites. Crit Reviews\u2122 Eukaryot Gene Expression, 17","DOI":"10.1615\/CritRevEukarGeneExpr.v17.i1.30"},{"key":"6606_CR25","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s12275-018-8032-4","volume":"56","author":"N Kim","year":"2018","unstructured":"Kim N, Yun M, Oh YJ, Choi H-J (2018) Mind-altering with the gut: modulation of the gut-brain axis with probiotics. J Microbiol 56:172\u2013182","journal-title":"J Microbiol"},{"key":"6606_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7525-6-12","volume":"6","author":"KR Kulich","year":"2008","unstructured":"Kulich KR, Madisch A, Pacini F, Piqu\u00e9 JM, Regula J, Van Rensburg CJ, \u00dajsz\u00e1szy L, Carlsson J, Halling K, Wiklund IK (2008) Reliability and validity of the gastrointestinal Symptom Rating Scale (GSRS) and quality of life in reflux and dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study. Health Qual Life Outcomes 6:1\u201312","journal-title":"Health Qual Life Outcomes"},{"key":"6606_CR27","doi-asserted-by":"crossref","unstructured":"Lei Q, Wu T, Wu J, Hu X, Guan Y, Wang Y, Yan J, Shi G (2021) Roles of alpha\u2013synuclein in gastrointestinal microbiome dysbiosis\u2013related Parkinson\u2019s disease progression (Review). Mol Med Rep, 24","DOI":"10.3892\/mmr.2021.12374"},{"key":"6606_CR28","doi-asserted-by":"crossref","unstructured":"Macmahon Copas AN, Mccomish SF, Fletcher JM, Caldwell MA (2021) The Pathogenesis of Parkinson\u2019s Disease: A Complex Interplay Between Astrocytes, Microglia, and T Lymphocytes? Front Neurol, 12, 666737","DOI":"10.3389\/fneur.2021.666737"},{"key":"6606_CR29","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3389\/fimmu.2019.00969","volume":"10","author":"L Magistrelli","year":"2019","unstructured":"Magistrelli L, Amoruso A, Mogna L, Graziano T, Cantello R, Pane M, Comi C (2019) Probiotics may have beneficial effects in Parkinson\u2019s disease: in vitro evidence. Front Immunol 10:969","journal-title":"Front Immunol"},{"key":"6606_CR30","doi-asserted-by":"publisher","first-page":"105397","DOI":"10.1016\/j.jff.2022.105397","volume":"100","author":"S Mehrabani","year":"2023","unstructured":"Mehrabani S, Khorvash F, Heidari Z, Tajabadi-Ebrahimi M, Amani R (2023) The effects of synbiotic supplementation on oxidative stress markers, mental status, and quality of life in patients with Parkinson\u2019s disease: a double-blind, placebo-controlled, randomized controlled trial. J Funct Foods 100:105397","journal-title":"J Funct Foods"},{"key":"6606_CR31","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1055\/s-0042-122136","volume":"67","author":"Z Mohammadi","year":"2017","unstructured":"Mohammadi Z, Sharif Zak M, Seidi K, Barati M, Akbarzadeh A, Zarghami N (2017) The Effect of Chrysin Loaded PLGA-PEG on Metalloproteinase Gene expression in mouse 4T1 Tumor Model. Drug Res (Stuttg) 67:211\u2013216","journal-title":"Drug Res (Stuttg)"},{"key":"6606_CR32","doi-asserted-by":"crossref","unstructured":"Pajares M, Manda AIR, Bosca G, L., Cuadrado A (2020) Inflammation in Parkinson\u2019s Disease. Mechanisms and Therapeutic Implications. Cells, p 9","DOI":"10.3390\/cells9071687"},{"key":"6606_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13099-023-00536-1","volume":"15","author":"JM Park","year":"2023","unstructured":"Park JM, Lee SC, Ham C, Kim YW (2023) Effect of probiotic supplementation on gastrointestinal motility, inflammation, motor, non-motor symptoms and mental health in Parkinson\u2019s disease: a meta-analysis of randomized controlled trials. Gut Pathog 15:9","journal-title":"Gut Pathog"},{"key":"6606_CR34","doi-asserted-by":"crossref","unstructured":"Pignolo A, Mastrilli S, Davi C, Arnao V, Aridon P, Dos Santos Mendes FA, Gagliardo C (2022) Vitamin D and Parkinson\u2019s Disease. & D\u2019Amelio, M., p 14","DOI":"10.3390\/nu14061220"},{"key":"6606_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3233\/JPD-150615","volume":"6","author":"LM Rimmelzwaan","year":"2016","unstructured":"Rimmelzwaan LM, Van Schoor NM, Lips P, Berendse HW, Eekhoff EM (2016) Systematic review of the relationship between vitamin D and Parkinson\u2019s disease. J Parkinson\u2019s Disease 6:29\u201337","journal-title":"J Parkinson\u2019s Disease"},{"key":"6606_CR36","doi-asserted-by":"publisher","first-page":"4375","DOI":"10.1002\/ptr.7937","volume":"37","author":"T\u00d6 \u015eahin","year":"2023","unstructured":"\u015eahin T\u00d6, Yilmaz B, Ye\u015filyurt N, Cicia D, Szymanowska A, Amero P, A\u011fag\u00fcnd\u00fcz D, Capasso R (2023) Recent insights into the nutritional immunomodulation of cancer-related microRNAs. Phytother Res 37:4375\u20134397","journal-title":"Phytother Res"},{"key":"6606_CR37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jnutbio.2019.03.021","volume":"69","author":"S Srivastav","year":"2019","unstructured":"Srivastav S, Neupane S, Bhurtel S, Katila N, Maharjan S, Choi H, Hong JT, Choi D-Y (2019) Probiotics mixture increases butyrate, and subsequently rescues the nigral dopaminergic neurons from MPTP and rotenone-induced neurotoxicity. J Nutr Biochem 69:73\u201386","journal-title":"J Nutr Biochem"},{"key":"6606_CR38","doi-asserted-by":"publisher","first-page":"a009399","DOI":"10.1101\/cshperspect.a009399","volume":"2","author":"L Stefanis","year":"2012","unstructured":"Stefanis L (2012) \u03b1-Synuclein in Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2:a009399","journal-title":"Cold Spring Harb Perspect Med"},{"key":"6606_CR39","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/jgh3.12450","volume":"5","author":"AH Tan","year":"2021","unstructured":"Tan AH, Hor JW, Chong CW, Lim SY (2021a) Probiotics for Parkinson\u2019s disease: current evidence and future directions. JGH Open 5:414\u2013419","journal-title":"JGH Open"},{"key":"6606_CR40","doi-asserted-by":"crossref","unstructured":"Tan AH, Lim S-Y, Chong KK, Manap A, Hor MAA, Lim JW, Low JL, Chong SC, Mahadeva CW, S., Lang AE (2021b) Probiotics for constipation in Parkinson disease: a randomized placebo-controlled study. Neurology 96:e772\u2013e782","DOI":"10.1212\/WNL.0000000000010998"},{"key":"6606_CR41","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.3390\/antiox11112287","volume":"11","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhang Z, Li B, He B, Li L, Nice EC, Zhang W, Xu J (2022) New insights into the gut microbiota in neurodegenerative diseases from the perspective of Redox Homeostasis. Antioxidants 11:2287","journal-title":"Antioxidants"},{"key":"6606_CR42","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fnagi.2018.00109","volume":"10","author":"X-S Zeng","year":"2018","unstructured":"Zeng X-S, Geng W-S, Jia J-J, Chen L, Zhang P-P (2018) Cellular and molecular basis of neurodegeneration in Parkinson disease. Front Aging Neurosci 10:109","journal-title":"Front Aging Neurosci"},{"key":"6606_CR43","doi-asserted-by":"publisher","first-page":"937555","DOI":"10.3389\/fimmu.2022.937555","volume":"13","author":"M Zhu","year":"2022","unstructured":"Zhu M, Liu X, Ye Y, Yan X, Cheng Y, Zhao L, Chen F, Ling Z (2022) Gut microbiota: a novel therapeutic target for Parkinson\u2019s disease. Front Immunol 13:937555","journal-title":"Front Immunol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-024-06606-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-024-06606-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-024-06606-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T08:31:45Z","timestamp":1724401905000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-024-06606-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["6606"],"URL":"https:\/\/doi.org\/10.1007\/s00213-024-06606-9","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,28]]},"assertion":[{"value":"18 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}